Representative Work Representative Work

Canvass Analytics in its US$5 million financing

On August 21, 2018, Canvass Analytics announced that it has closed a US$5 million financing round, led by Gradient Ventures. Additional participation came from Bedrock Industries, Viaduct Ventures and existing investors Real Ventures and Barney Pell. Canvass Analytics’ use of artificial...

Lead Office: Toronto Date Closed: August 21, 2018 Value: US$5 million

Caprion Biosciences in its acquisition of Primity Bio

On August 21, 2018, Caprion Biosciences announced that it has acquired Primity Bio Inc.  Caprion will leverage Primity's strong technological capabilities and innovative track record to further expand its immunology and molecular profiling service offering as well as its...

Lead Office: Toronto Date Closed: August 21, 2018 Value: -

Zensurance in its sale of a majority stake to The Travelers Companies, Inc.

On August 15, 2018, The Travelers Companies, Inc. acquired a majority stake in Zensurance through a wholly-owned subsidiary. Pairing with Travelers would provide an opportunity to gain more insight into the insurance industry and build up Zensurance’s technology. It will also provide...

Lead Office: Toronto Date Closed: August 15, 2018 Value: -

Pattern Energy invests US$60 million in Pattern Development and forms strategic relationship with PSP Investments

On June 19, 2017, Pattern Energy Group Inc. (“Pattern Energy”), Pattern Development 1.0 and Pattern Development 2.0 (together “Pattern Development”), Riverstone Holdings LLC, and the Public Sector Pension Investment Board (“PSP Investments”)...

Lead Office: Toronto Date Closed: August 14, 2018 Value: US$60 million

The Underwriters in connection with Stella-Jones Inc.’s secondary public offering and private placement by Stella Jones International S.A.

On August 14, 2018,  Stella-Jones Inc ("Stella-Jones") announced that Stella Jones International S.A. ("SJ International") has completed its previously announced secondary public offering pursuant to which SJ International sold, on a bought deal basis, to a syndicate of underwriters, led by TD...

Lead Office: Toronto Date Closed: August 14, 2018 Value: $876.5 million

Panavision Inc. in its acquisition by Saban Capital Acquisition Corp and combination with Sim to form Panavision Holdings

On September 13, 2018, Saban Capital Acquisition Corp. (“Saban”), a publicly traded special purpose acquisition company, Panavision Inc. ("Panavision"), and Sim Video International Inc. ("Sim") announced that the companies have entered into a definitive business...

Lead Office: Toronto Date Closed: -- Value: US$622 million

Chinova Bioworks in its $2.6 million Seed financing

On August 13, 2018, Chinova Bioworks Inc. announced it has completed its seed round of $2.6 million. The round was led by DSM Venturing BV and Rhapsody Venture Partners, with participation from AgFunder and Natural Products Canada. Chinova Bioworks plans to use the funding to build its...

Lead Office: Toronto Date Closed: August 13, 2018 Value: $2.6 million

South32 in its $2.1 billion acquisition of Arizona Mining

Osler represented South32 in connection with its announced acquisition of Arizona Mining in an all-cash transaction valued at C$2.1 billion. South32 is a globally diversified mining and metals company with high quality operations in Australia, Southern Africa and South America. Arizona Mining is...

Lead Office: Vancouver Date Closed: August 10, 2018 Value: $2.1 billion

Behaviour Interactive Inc. in its strategic partnership agreement with GAEA Interactive Entertainment Co. Ltd.

On October 16, 2018, Behaviour Interactive Inc. (“Behaviour”) and Beijing’s GAEA Interactive Entertainment Co. Ltd (“GAEA”) announced a strategic partnership. GAEA made a 20% strategic investment in Behaviour. This investment will fuel Behaviour’s continuous growth and accelerate its...

Lead Office: Montreal Date Closed: August 9, 2018 Value: -

Angiochem Inc. in its Series C financing round of $7.5 million

On August 1, 2018, Angiochem Inc. announced that it had completed its Series C financing round of $7.5 million. Angiochem Inc. plans to use the financing to support the development of ANG1005, its treatment for leptomeningeal carcinomatosis caused by breast cancer. There are currently no...

Lead Office: Montreal Date Closed: August 1, 2018 Value: $7.5 million